This list is an analysis based on recent market events. It's not an investment recommendation.
About
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products, including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries. This segment focuses on various therapeutic areas, such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. Its Proprietary Brands segment develops, markets, and sells dermatological products comprising Ceradan, TDF, and CG210; health supplements under the Ocean Health brand covering areas, such as heart, joint, physical, cognitive, eye, and health; and pharmaceuticals. The Digital Platform and E-Pharmacy segment operates a digital platform that services procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies primarily in Singapore. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
What is Hyphens Pharma International Limited stock price today?▼
The current price of 1J5.SG is S$0.36 SGD — it has increased by +4.41% in the past 24 hours. Watch Hyphens Pharma International Limited stock price performance more closely on the chart.
What is Hyphens Pharma International Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hyphens Pharma International Limited stocks are traded under the ticker 1J5.SG.
Is Hyphens Pharma International Limited stock price growing?▼
1J5.SG stock has risen by +7.58% compared to the previous week, the month change is a +12.7% rise, over the last year Hyphens Pharma International Limited has showed a +22.41% increase.
What is Hyphens Pharma International Limited market cap?▼
Today Hyphens Pharma International Limited has the market capitalization of 109.65M
When is the next Hyphens Pharma International Limited earnings date?▼
Hyphens Pharma International Limited is going to release the next earnings report on August 19, 2026.
What were Hyphens Pharma International Limited earnings last quarter?▼
1J5.SG earnings for the last quarter are 0.01 SGD per share, whereas the estimation was N/A SGD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A SGD per share.
What is Hyphens Pharma International Limited revenue for the last year?▼
Hyphens Pharma International Limited revenue for the last year amounts to 444.28M SGD.
What is Hyphens Pharma International Limited net income for the last year?▼
1J5.SG net income for the last year is 13.37M SGD.
Does Hyphens Pharma International Limited pay dividends?▼
Yes, 1J5.SG dividends are paid annual. The last dividend per share was 0.02 SGD. As of today, Dividend Yield (FWD)% is 4.23%.
How many employees does Hyphens Pharma International Limited have?▼
As of April 27, 2026, the company has 455 employees.
In which sector is Hyphens Pharma International Limited located?▼
Hyphens Pharma International Limited operates in the Essentials sector.
When did Hyphens Pharma International Limited complete a stock split?▼
Hyphens Pharma International Limited has not had any recent stock splits.
Where is Hyphens Pharma International Limited headquartered?▼
Hyphens Pharma International Limited is headquartered in Singapore, Singapore.